// App-Quantinova.ai

12088 : Early assessment of treatment effect in advanced lung adenocarcinoma via longitudinal ctDNA analysis.

Researchers

Presenter

  • Xiaoju Max Ma

Principal Investigators

  • Stephanie Yaung

  • Nalin Tikoo

  • Aarthi Balasubramanyam

  • Christine Ju

  • Dan Klass

  • Alexander F. Lovejoy

  • Amrita Pati

  • Owen Solberg

  • Yuqiu Jiang

  • Hans-Peter Adams

  • Birgit Wehnl

  • Michael Thomas

  • Felix Lasitschka

  • Michael Meister

  • Marc Schneider

  • Felix Herth

  • John F. Palma

  • Thomas Muley

Medical Centers

  • Roche Molecular Systems, Pleasanton, CA

  • Roche Sequencing Solutions, Pleasanton, CA

  • Roche Sequencing, Pleasanton, CA

  • Pfizer Oncology, La Jolla, CA

  • Signature Diagnostics GmbH, Potsdam, DE

  • Roche Diagnostics GmbH, Penzberg, Germany

  • University Clinic Heidelberg, Heidelberg, Germany

  • Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

  • Thoraxklinik at Heidelberg University Hospital, Null, Germany

  • Thoraxklinik at Heidelberg University Hospital, Null, Germany

  • Roche, Pleasanton, CA

Locations

  • United States

  • Germany

Companies

  • Feng Chi Biotech Cor

  • F. Hoffmann-La Roche

  • PharmAbcine Inc.

  • Signature Diagnostic

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved